MAPK Signaling
Activated MAPKs transduce the phosphorylation and activation of MAPK-activated protein kinases (MAPKAPKs), e.g. RSK, MSK, or MNK family, and MK2/3/5. There are three main MAPK families, signal-regulated kinase 1 and 2 (Erk1/2 or p44/42), the c-Jun N-terminal kinases 1-3 (JNK1-3)/ stress activated protein kinases (SAPK1A, 1B, 1C), the p38 isoforms (p38α, β, γ, and δ). ERK signaling is involved in cell division, migration and survival. p38 MAPK and JNK/SAPK pathways are activated by cellular stress. The p38 MAPK pathway regulates cell motility, transcription, and chromatin remodeling. JNK/SAPK signaling affects apoptosis and inflammation. Dysregulation of MAPK pathway results in tumorgenesis and other pathological conditions.
- A4604 SP 6001257 CitationTarget: JNKSummary: JNK1/2/3 inhibitor
- A1663 PD980599 CitationTarget: MEKSummary: MEK inhibitor,selective and reversible
- B1407 Dabrafenib (GSK2118436)3 CitationTarget: RafSummary: Inhibitor of BRAF(V600) mutants
- B1106 VRT752271Target: ERKSummary: ERK1/ERK2 inhibitor
- B6962 CMPD-1Target: Microtubules/Tubulins|MK2Summary: inhibitor of p38α-mediated MK2a phosphorylation